December 2021 and December 2022 could not have been more contrasting for India’s pharmaceutical industry. This year, two Indian drug-manufacturing firms stand accused by two countries of producing toxic cough syrup linked to the deaths of children — at least 66 in The Gambia and 18 in Uzbekistan. While the export licence of the Haryana-based Maiden Pharmaceuticals Ltd., which supplied …
